​

Funding Round

Series B - Surginex

Series B - Surginex

Investment Firm

Overview

Surginex is a biological drug development company that offers molecular biology, genetics, physical, and chemical analysis services.

Announced Date

Mar 27, 2024

Funding Type

Series B

Highlights

Location

Asia

Social

N/A

Investor Lead

N/A

Participant Investors

6

Investor Name
Participant InvestorLaguna Investment
Participant InvestorHana Ventures
Participant InvestorPartners Investment
Participant InvestorPOSCO CAPITAL
Participant InvestorKiwoom Investment

Round Details and Background

Surginex raised $6293860 on 2024-03-27 in Series B

Surginex is a biological drug development company that offers molecular biology, genetics, physical, and chemical analysis services.

Company Funding History

2

Announcment DateTransaction NameNumber Of InvestorsLead InvestorMoney Raised
Nov 11, 2021
Series A - Surginex
2-3.4M
Mar 27, 2024
Series B - Surginex
6-6.3M

Recent Activity

There is no recent news or activity for this profile.